Blood Glucose Monitoring System Market by Product (Self-Monitoring, Continuous Glucose Monitoring Devices), Testing Site (Fingertip), Patient Care Setting (Hospital, Homecare), Application (Type 1, Type 2, Gestational Diabetes) & Geography
The global blood glucose monitoring system market is projected to grow at a CAGR of 4.8%. Rising prevalence of diabetic population, and increasing innovative product launches are factors driving the growth in the market.
Objectives of the Study
- To define, describe, and forecast the global market by product, testing site, patient care setting, application, and region
- To provide detailed information regarding major factors influencing growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast size of market segments with respect to the four main regions, namely, North America (US and Canada), Europe (Germany, UK, France, and Rest of Europe), Asia Pacific (China, Japan, India, and Rest of APAC), and the Rest of the World (Latin America and Middle East & Africa)
- To strategically analyze the market structure and profile key players of the global market and comprehensively analyze their core competencies
- To track and analyze company developments such as partnerships, agreements and collaborations; expansions; acquisitions; and product launches in the market
Research Methodology
Top-down and bottom-up approaches were used to validate the size of the global blood glucose monitoring system market and estimate the size of other dependent submarkets. Various secondary sources such as, Annual Reports, Press Releases, International Diabetes Federation, World Health Organization (WHO), American Diabetes Association, JDRF, Madras Diabetes Research Foundation (MDRF), India Diabetes Research Foundation (IDRF), Chinese Diabetes Society (CDS), Russian Diabetes Federation, Brazilian Diabetes Society, Latin American Diabetes Association (ALAD), European Association for the Study of Diabetes (EASD), American Association of Diabetes Educators (AADE), Press Releases, directories, industry journals, databases, and annual reports of the companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:
To know about the assumptions considered for the study, download the pdf brochure
The major players in the global blood glucose monitoring system market are Roche (Switzerland), Abbott (US), LifeScan (US), Ascensia (Switzerland), Medtronic (Ireland), Dexcom (US), Ypsomed (Switzerland), B. Braun (Germany), Nipro (Japan), Sanofi (France), ARKRAY (Japan), Prodigy Diabetes Care (US), ACON Laboratories (US), and Nova Biomedical (US).
Target Audience:
- Blood glucose monitoring systems and related devices manufacturers
- Suppliers and distributors of blood glucose monitoring systems
- Hospitals, diagnostic centers, homecare service providers, and medical colleges
- Teaching hospitals and academic medical centers
- Government bodies/municipal corporations
- Business research and consulting service providers
- Venture capitalists
Blood Glucose Monitoring System Market Report Scope
The research report categorizes the market into the following segments and subsegments:
Blood Glucose Monitoring System Market, by Product
-
Self-Monitoring Blood Glucose Systems
- Blood Glucose meters
- Testing strips
- Lancets & Lancing Devices
-
Continuous Glucose Monitoring Systems
- Sensors
- Transmitters
- Receivers
Blood Glucose Monitoring System Market, by Testing Site
- Fingertip testing
- Alternate Site Testing
Blood Glucose Monitoring System Market, by Patient Care Setting
- Self/Home Care
- Hospital & Clinics
Blood Glucose Monitoring System Market, by Application
- Type 2 Diabetes
- Type 1 Diabetes
- Gestational Diabetes
Blood Glucose Monitoring System Market, by Region
- North America
- Europe
- Asia Pacific
- Rest of the World
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of each company
Company Information
- Detailed analysis and profiling of additional market players (up to 3)
The market is segmented on the basis of product, testing site, patient care setting, application, and region. Based on product, the market is segmented into self-monitoring blood glucose systems and continuous glucose monitoring systems. The continuous glucose monitoring system segment is expected to grow at the highest CAGR during the forecast period. The high growth in the continuous glucose monitoring system segment can be primarily attributed to the rising adoption of minimally invasive procedures.
On the basis of testing site, the global market is segmented into fingertip testing and alternate site testing. The fingertip testing segment is expected to account for the largest of the global market and is expected to register the highest CAGR. This can be primarily attributed to the accuracy and high reliability of fingertip testing.
On the basis of patient care setting, the global market is categorized into self/home care and hospital & clinics. The self/home care segment is estimated to account for the largest of the global blood glucose monitoring system market and is expected to register the highest CAGR. This can primarily be attributed to growing diabetic population, and increasing awareness about regular monitoring of glucose levels and increasing product launches enhancing patient comfort when used at home.
Based on application, the market is categorized into type 1 diabetes, type 2 diabetes, and gestational diabetes. The type 2 diabetes segment is estimated to command the largest share of the blood glucose monitoring systems market. The large share can be attributed to increasing incidence of type 2 diabetes, and increasing innovative product launches with less invasive technologies.
Geographic segments in this report include North America, Europe, Asia Pacific, and RoW. Of these, the North American segment is expected to account for the largest share of the market in 2017. The large share of this region can primarily be attributed to the favorable reimbursements, awareness programs, rising FDA approvals in the US, and rising prevalence of diabetes in the US and Canada.
The high cost and poor reimbursements of blood glucose monitoring systems and supplies is expected to restrain the growth of this market during the forecast period. For instance, in emerging countries such as China and India, patients bear the expenses of the blood glucose monitors and testing strips. Additionally in developed countries such as Canada and some European nations there is a limitation on the quantity of testing strips supplied per patient per year based on the treatment plan of the patient
The major players in Blood Glucose Monitoring System Market include F.Hoffman-la Roche (Switzerland), Abbott Laboratories (US), LifeScan (US), Ascensia Diabetes Care (Switzerland), Medtronic (Ireland), Dexcom (US), Ypsomed (Switzerland), B. Braun Melsungen (Germany), Nipro (Japan), Sanofi (France), ARKRAY (Japan), Prodigy Diabetes Care (US), ACON Laboratories (US), and Nova Biomedical (US).
Roche is one of the leading companies in the market, as it offers an extensive range of glucometers and lancets. To maintain its market position in diabetes care, the company focuses on expanding its product portfolio through acquisitions. For instance, in 2017, the company acquired mySugr GmbH, which is likely to expand Roche’s product portfolio in the area of diabetes management. Geographically, Roche has a strong presence in North America, Europe, and Asia Pacific. Its strong distribution channels help it to cater to the rising demand for diabetes care devices across the globe. However, increasingly stringent government regulations and global financial fluctuations are major threats to the company’s revenue generation.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Table of Contents
1 Blood Glucose Monitoring System Market: Introduction (Page No. - 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Blood Glucose Monitoring System Market: Research Methodology (Page No. - 20)
2.1 Research Design
2.2 Research Approach
2.2.1 Secondary Research
2.2.2 Primary Research
2.3 Market Size Estimation
2.4 Market Data Validation and Triangulation
2.5 Assumptions for the Study
3 Blood Glucose Monitoring System Market: Executive Summary (Page No. - 30)
4 Blood Glucose Monitoring System Market: Premium Insights (Page No. - 35)
4.1 Global Blood Glucose Monitoring Systems: Market Overview
4.2 Global Market, By Product
4.3 Geographic Analysis: Global Self-Monitoring/ Traditional Blood Glucose Systems Market, By Component
4.4 Global Continuous Glucose Monitoring Systems Market, By Component
4.5 Global Market, By Patient Care Setting
4.6 Global Market, By Application
4.7 Global Market, By Testing Site
4.8 Geographic Snapshot: Global Market
5 Blood Glucose Monitoring System Market: Overview (Page No. - 40)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Prevalence of Diabetes
5.2.1.2 Increasing Number of Product Launches
5.2.2 Restraint
5.2.2.1 High Cost and Poor Reimbursement of Blood Glucose Monitoring Systems and Supplies
5.2.3 Opportunity
5.2.3.1 Pipeline Products and Ongoing Research
5.2.4 Challenge
5.2.4.1 Invasiveness of Blood Glucose Monitors
6 Blood Glucose Monitoring System Market, By Product (Page No. - 45)
6.1 Introduction
6.2 Self-Monitoring Blood Glucose Systems
6.2.1 Blood Glucose Meters
6.2.2 Testing Strips
6.2.3 Lancets & Lancing Devices
6.3 Continuous Glucose Monitoring Systems
6.3.1 Sensors
6.3.2 Transmitters
6.3.3 Receivers
7 Blood Glucose Monitoring System Market, By Testing Site (Page No. - 57)
7.1 Introduction
7.2 Fingertip Testing
7.3 Alternate Site Testing
8 Blood Glucose Monitoring System Market, By Patient Care Setting (Page No. - 61)
8.1 Introduction
8.2 Self/Home Care
8.3 Hospitals & Clinics
9 Blood Glucose Monitoring System Market, By Application (Page No. - 65)
9.1 Introduction
9.2 Diabetes
9.2.1 Type 2 Diabetes
9.2.1.1 Adults
9.2.1.2 Pediatrics
9.2.2 Type 1 Diabetes
9.2.2.1 Adults
9.2.2.2 Pediatrics
9.2.3 Gestational Diabetes
10 Blood Glucose Monitoring System Market, By Region (Page No. - 73)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Rest of Europe (RoE)
10.4 Asia Pacific (APAC)
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 Rest of APAC
10.5 Rest of the World (RoW)
11 Blood Glucose Monitoring System Market: Competitive Landscape (Page No. - 130)
11.1 Overview
11.2 Market Share Analysis
11.2.1 Self-Monitoring/Traditional Blood Glucose Systems Market
11.2.2 Continuous Glucose Monitoring Systems Market
11.3 Competitive Scenario
11.3.1 Product Launches and Approvals
11.3.2 Agreements, Collaborations, Contracts, and Partnerships
11.3.3 Expansions
11.3.4 Acquisitions
12 Company Profiles (Page No. - 138)
(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*
12.1 Abbott Laboratories
12.2 F. Hoffmann-La Roche
12.3 Lifescan
12.4 Ascensia Diabetes Care
12.5 Dexcom
12.6 Medtronic
12.7 Ypsomed
12.8 B. Braun Melsungen
12.9 Nipro
12.10 Sanofi
12.11 Arkray
12.12 Prodigy Diabetes Care
12.13 Acon Laboratories
12.14 Nova Biomedical
*Details on Marketsandmarkets View, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments Might Not Be Captured in Case of Unlisted Companies.
13 Appendix (Page No. - 170)
13.1 Discussion Guide
13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.3 Introducing RT: Real-Time Market Intelligence
13.4 Available Customizations
13.5 Related Reports
13.6 Author Details
List of Tables (160 Tables)
Table 1 Top 10 Countries With the Highest Number of Diabetics (20–79 Years), 2017 vs 2045
Table 2 Blood Glucose Monitoring Systems Market, By Product, 2015–2022 (USD Million)
Table 3 Self-Monitoring Blood Glucose Systems Market, By Component, 2015–2022 (USD Million)
Table 4 Self-Monitoring Blood Glucose Systems Market, By Component, 2015–2022 (Thousand Units)
Table 5 Blood Glucose Meters Market, By Region, 2015–2022 (USD Million)
Table 6 Blood Glucose Meters Market, By Region, 2015–2022 (Thousand Units)
Table 7 Testing Strips Market, By Region, 2015–2022 (USD Million)
Table 8 Testing Strips Market, By Region, 2015–2022 (Thousand Units)
Table 9 Lancing Devices Market, By Region, 2015–2022 (USD Million)
Table 10 Lancing Devices Market, By Region, 2015–2022 (Thousand Units)
Table 11 Lancets Market, By Region, 2015–2022 (USD Million)
Table 12 Lancets Market, By Region, 2015–2022 (Thousand Units)
Table 13 Continuous Glucose Monitoring Systems Market, By Component, 2015–2022 (USD Million)
Table 14 Continuous Glucose Monitoring Systems Market, By Component, 2015–2022 (Thousand Units)
Table 15 Sensors Market, By Component, 2015–2022 (USD Million)
Table 16 Sensors Market, By Component, 2015–2022 (Thousand Units)
Table 17 Transmitters Market, By Region, 2015–2022 (USD Million)
Table 18 Transmitters Market, By Region, 2015–2022 (Thousand Units)
Table 19 Receivers Market, By Region, 2015–2022 (USD Million)
Table 20 Receivers Market, By Region, 2015–2022 (Thousand Units)
Table 21 Blood Glucose Monitoring System Market, By Testing Site, 2015–2022 (USD Million)
Table 22 Global Market for Fingertip Testing, By Region, 2015–2022 (USD Million)
Table 23 Global Market for Alternate Site Testing, By Region, 2015–2022 (USD Million)
Table 24 Global Market, By Patient Care Setting, 2015–2022 (USD Million)
Table 25 Global Market for Home/Self Care, By Region, 2015–2022 (USD Million)
Table 26 Global Market for Hospitals & Clinics, By Region, 2015–2022 (USD Million)
Table 27 Market, By Application, 2015–2022 (USD Million)
Table 28 Global Market for Type 2 Diabetes, By Type, 2015–2022 (USD Million)
Table 29 Global Market for Type 2 Diabetes, By Region, 2015–2022 (USD Million)
Table 30 Global Market for Type 2 Diabetes in Adults, By Region, 2015–2022 (USD Million)
Table 31 Global Market for Type 2 Diabetes in Pediatrics, By Region, 2015–2022 (USD Million)
Table 32 Global Market for Type 1 Diabetes, By Type, 2015–2022 (USD Million)
Table 33 Blood Glucose Monitoring System Market for Type 1 Diabetes, By Region, 2015–2022 (USD Million)
Table 34 Global Market for Type 1 Diabetes in Adults, By Region, 2015–2022 (USD Million)
Table 35 Global Market for Type 1 Diabetes in Pediatrics, By Region, 2015–2022 (USD Million)
Table 36 Global Market for Gestational Diabetes, By Region, 2015–2022 (USD Million)
Table 37 Global Market, By Region, 2015–2022 (USD Million)
Table 38 North America: Market, By Country, 2015–2022 (USD Million)
Table 39 North America: Market, By Product, 2015–2022 (USD Million)
Table 40 North America: Self-Monitoring Glucose Systems Market, By Component, 2015–2022 (USD Million)
Table 41 North America: Self-Monitoring Glucose Systems Market, By Component, 2015–2022 (Thousand Units)
Table 42 North America: Continuous Glucose Monitoring Systems Market, By Component, 2015–2022 (USD Million)
Table 43 North America: Continuous Glucose Monitoring Systems Market, By Component, 2015–2022 (Thousand Units)
Table 44 North America: Market, By Testing Site, 2015–2022 (USD Million)
Table 45 North America: Market, By Patient Care Setting, 2015–2022 (USD Million)
Table 46 North America: Market, By Application, 2015–2022 (USD Million)
Table 47 Fda Approvals of Blood Glucose Monitoring Systems (2014–2017)
Table 48 US: Blood Glucose Monitoring System Market, By Product, 2015–2022 (USD Million)
Table 49 US: Self-Monitoring Glucose Systems Market, By Component, 2015–2022 (USD Million)
Table 50 US: Self-Monitoring Glucose Systems Market, By Component, 2015–2022 (Thousand Units)
Table 51 US: Continuous Glucose Monitoring Systems Market, By Component, 2015–2022 (USD Million)
Table 52 US: Continuous Glucose Monitoring Systems Market, By Component, 2015–2022 (Thousand Units)
Table 53 US: Market, By Testing Site, 2015–2022 (USD Million)
Table 54 US: Market, By Patient Care Setting, 2015–2022 (USD Million)
Table 55 US: Market, By Application, 2015–2022 (USD Million)
Table 56 Quantity Limits for Blood Glucose Test Strips
Table 57 Canada: Blood Glucose Monitoring System Market, By Product, 2015–2022 (USD Million)
Table 58 Canada: Self-Monitoring Glucose Systems Market, By Component, 2015–2022 (USD Million)
Table 59 Canada: Self-Monitoring Glucose Systems Market, By Component, 2015–2022 (Thousand Units)
Table 60 Canada: Continuous Glucose Monitoring Systems Market, By Component, 2015–2022 (USD Million)
Table 61 Canada: Continuous Glucose Monitoring Systems Market, By Component, 2015–2022 (Thousand Units)
Table 62 Canada: Market, By Testing Site, 2015–2022 (USD Million)
Table 63 Canada: Market, By Patient Care Setting, 2015–2022 (USD Million)
Table 64 Canada: Market, By Application, 2015–2022 (USD Million)
Table 65 Europe: Blood Glucose Monitoring System Market, By Country, 2015–2022 (USD Million)
Table 66 Europe: Market, By Product, 2015–2022 (USD Million)
Table 67 Europe: Self-Monitoring Glucose Systems Market, By Component, 2015–2022 (USD Million)
Table 68 Europe: Self-Monitoring Glucose Systems Market, By Component, 2015–2022 (Thousand Units)
Table 69 Europe: Continuous Glucose Monitoring Systems Market, By Component, 2015–2022 (USD Million)
Table 70 Europe: Continuous Glucose Monitoring Systems Market, By Component, 2015–2022 (Thousand Units)
Table 71 Europe: Market, By Testing Site, 2015–2022 (USD Million)
Table 72 Europe: Market, By Patient Care Setting, 2015–2022 (USD Million)
Table 73 Europe: Market, By Application, 2015–2022 (USD Million)
Table 74 Germany: Blood Glucose Monitoring System Market, By Product, 2015–2022 (USD Million)
Table 75 Germany: Self-Monitoring Glucose Systems Market, By Component, 2015–2022 (USD Million)
Table 76 Germany: Self-Monitoring Glucose Systems Market, By Component, 2015–2022 (Thousand Units)
Table 77 Germany: Continuous Glucose Monitoring Systems Market, By Component, 2015–2022 (USD Million)
Table 78 Germany: Continuous Glucose Monitoring Systems Market, By Component, 2015–2022 (Thousand Units)
Table 79 Germany: Blood Glucose Monitoring Systems Market, By Testing Site, 2015–2022 (USD Million)
Table 80 Germany: Market, By Patient Care Setting, 2015–2022 (USD Million)
Table 81 Germany: Blood Glucose Monitoring Systems Market, By Application, 2015–2022 (USD Million)
Table 82 UK: Blood Glucose Monitoring System Market, By Product, 2015–2022 (USD Million)
Table 83 UK: Self-Monitoring Glucose Systems Market, By Component, 2015–2022 (USD Million)
Table 84 UK: Self-Monitoring Glucose Systems Market, By Component, 2015–2022 (Thousand Units)
Table 85 UK: Continuous Glucose Monitoring Systems Market, By Component, 2015–2022 (USD Million)
Table 86 UK: Continuous Glucose Monitoring Systems Market, By Component, 2015–2022 (Thousand Units)
Table 87 UK: Market, By Testing Site, 2015–2022 (USD Million)
Table 88 UK: Blood Glucose Monitoring Systems Market, By Patient Care Setting, 2015–2022 (USD Million)
Table 89 UK: Market, By Application, 2015–2022 (USD Million)
Table 90 France: Blood Glucose Monitoring System Market, By Product, 2015–2022 (USD Million)
Table 91 France: Self-Monitoring Glucose Systems Market, By Component, 2015–2022 (USD Million)
Table 92 France: Self-Monitoring Glucose Systems Market, By Component, 2015–2022 (Thousand Units)
Table 93 France: Continuous Glucose Monitoring Systems Market, By Component, 2015–2022 (USD Million)
Table 94 France: Continuous Glucose Monitoring Systems Market, By Component, 2015–2022 (Thousand Units)
Table 95 France: Blood Glucose Monitoring Systems Market, By Testing Site, 2015–2022 (USD Million)
Table 96 France: Market, By Patient Care Setting, 2015–2022 (USD Million)
Table 97 France: Market, By Application, 2015–2022 (USD Million)
Table 98 RoE: Blood Glucose Monitoring System Market, By Product, 2015–2022 (USD Million)
Table 99 RoE: Self-Monitoring Glucose Systems Market, By Component, 2015–2022 (USD Million)
Table 100 RoE: Self-Monitoring Glucose Systems Market, By Component, 2015–2022 (Thousand Units)
Table 101 RoE: Continuous Glucose Monitoring Systems Market, By Component, 2015–2022 (USD Million)
Table 102 RoE: Continuous Glucose Monitoring Systems Market, By Component, 2015–2022 (Thousand Units)
Table 103 RoE: Blood Glucose Monitoring Systems Market, By Testing Site, 2015–2022 (USD Million)
Table 104 RoE: Market, By Patient Care Setting, 2015–2022 (USD Million)
Table 105 RoE: Market, By Application, 2015–2022 (USD Million)
Table 106 Diabetes Prevalence in APAC, By Country
Table 107 APAC: Market, By Country, 2015–2022 (USD Million)
Table 108 APAC: Market, By Product, 2015–2022 (USD Million)
Table 109 APAC: Self-Monitoring Glucose Systems Market, By Component, 2015–2022 (USD Million)
Table 110 APAC: Self-Monitoring Glucose Systems Market, By Component, 2015–2022 (Thousand Units)
Table 111 APAC: Continuous Glucose Monitoring Systems Market, By Component, 2015–2022 (USD Million)
Table 112 APAC: Continuous Glucose Monitoring Systems Market, By Component, 2015–2022 (Thousand Units)
Table 113 APAC: Blood Glucose Monitoring Systems Market, By Testing Site, 2015–2022 (USD Million)
Table 114 APAC: Market, By Patient Care Setting, 2015–2022 (USD Million)
Table 115 APAC: Market, By Application, 2015–2022 (USD Million)
Table 116 China: Blood Glucose Monitoring System Market, By Product, 2015–2022 (USD Million)
Table 117 China: Self-Monitoring Glucose Systems Market, By Component, 2015–2022 (USD Million)
Table 118 China: Self-Monitoring Glucose Systems Market, By Component, 2015–2022 (Thousand Units)
Table 119 China: Continuous Glucose Monitoring Systems Market, By Component, 2015–2022 (USD Million)
Table 120 China: Continuous Glucose Monitoring Systems Market, By Component, 2015–2022 (Thousand Units)
Table 121 China: Blood Glucose Monitoring Systems Market, By Testing Site, 2015–2022 (USD Million)
Table 122 China: Market, By Patient Care Setting, 2015–2022 (USD Million)
Table 123 China: Blood Glucose Monitoring Systems Market, By Application, 2015–2022 (USD Million)
Table 124 India: Blood Glucose Monitoring System Market, By Product, 2015–2022 (USD Million)
Table 125 India: Self-Monitoring Glucose Systems Market, By Component, 2015–2022 (USD Million)
Table 126 India: Self-Monitoring Glucose Systems Market, By Component, 2015–2022 (Thousand Units)
Table 127 India: Continuous Glucose Monitoring Systems Market, By Component, 2015–2022 (USD Million)
Table 128 India: Continuous Glucose Monitoring Systems Market, By Component, 2015–2022 (Thousand Units)
Table 129 India: Blood Glucose Monitoring Systems Market, By Testing Site, 2015–2022 (USD Million)
Table 130 India: Market, By Patient Care Setting, 2015–2022 (USD Million)
Table 131 India: Market, By Application, 2015–2022 (USD Million)
Table 132 Japan: Blood Glucose Monitoring System Market, By Product, 2015–2022 (USD Million)
Table 133 Japan: Self-Monitoring Glucose Systems Market, By Component, 2015–2022 (USD Million)
Table 134 Japan: Self-Monitoring Glucose Systems Market, By Component, 2015–2022 (Thousand Units)
Table 135 Japan: Continuous Glucose Monitoring Systems Market, By Component, 2015–2022 (USD Million)
Table 136 Japan: Continuous Glucose Monitoring Systems Market, By Component, 2015–2022 (Thousand Units)
Table 137 Japan: Market, By Testing Site, 2015–2022 (USD Million)
Table 138 Japan: Market, By Patient Care Setting, 2015–2022 (USD Million)
Table 139 Japan: Market, By Application, 2015–2022 (USD Million)
Table 140 RoAPAC: Blood Glucose Monitoring System Market, By Product, 2015–2022 (USD Million)
Table 141 RoAPAC: Self-Monitoring Glucose Systems Market, By Component, 2015–2022 (USD Million)
Table 142 RoAPAC: Self-Monitoring Glucose Systems Market, By Component, 2015–2022 (Thousand Units)
Table 143 RoAPAC: Continuous Glucose Monitoring Systems Market, By Component, 2015–2022 (USD Million)
Table 144 RoAPAC: Continuous Glucose Monitoring Systems Market, By Component, 2015–2022 (Thousand Units)
Table 145 RoAPAC: Blood Glucose Monitoring Systems Market, By Testing Site, 2015–2022 (USD Million)
Table 146 RoAPAC: Market, By Patient Care Setting, 2015–2022 (USD Million)
Table 147 RoAPAC: Market, By Application, 2015–2022 (USD Million)
Table 148 Conference in Africa, Brazil, and the Middle East (2015–2017)
Table 149 RoW: Market, By Product, 2015–2022 (USD Million)
Table 150 RoW: Self-Monitoring Glucose Systems Market, By Component, 2015–2022 (USD Million)
Table 151 RoW: Self-Monitoring Glucose Systems Market, By Component, 2015–2022 (Thousand Units)
Table 152 RoW: Continuous Glucose Monitoring Systems Market, By Component, 2015–2022 (USD Million)
Table 153 RoW: Continuous Glucose Monitoring Systems Market, By Component, 2015–2022 (Thousand Units)
Table 154 RoW: Blood Glucose Monitoring Systems Market, By Testing Site, 2015–2022 (USD Million)
Table 155 RoW: Market, By Patient Care Setting, 2015–2022 (USD Million)
Table 156 RoW: Blood Glucose Monitoring Systems Market, By Application, 2015–2022 (USD Million)
Table 157 Product Launches and Approvals (2014-2017)
Table 158 Agreements, Collaborations, Contracts, and Partnerships
Table 159 Expansions
Table 160 Acquisitions
List of Figures (46 Figures)
Figure 1 Research Design: Global Blood Glucose Monitoring Systems Market
Figure 2 Global Blood Glucose Monitoring Systems Market: Research Methodology Steps
Figure 3 Secondary Sources
Figure 4 Sampling Frame: Primary Research
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 6 Primary Sources
Figure 7 Key Industry Insights
Figure 8 Market Size Estimation Methodology: Bottom-Up Approach
Figure 9 Market Size Estimation Methodology: Top-Down Approach
Figure 10 Data Triangulation Methodology
Figure 11 Self-Monitoring Blood Glucose Systems to Dominate the Global Market in 2017
Figure 12 Testing Strips to Dominate the Self-Monitoring/Traditional Blood Glucose Systems Market, By Component (2017)
Figure 13 Sensors to Dominate the Global Continuous Glucose Monitoring Systems Market, By Component (2017)
Figure 14 Blood Glucose Monitoring Systems Market, By Patient Care Setting (2017)
Figure 15 Type 2 Diabetes to Dominate the Blood Glucose Monitoring Systems Market, By Application (2017)
Figure 16 Fingertip Testing to Dominate the Blood Glucose Monitoring Systems Market, By Testing Site in 2017
Figure 17 North America is Slated to Witness the Highest Market Growth in the Blood Glucose Monitoring Systems Market During the Forecast Period
Figure 18 Product Enhancements in Blood Glucose Monitoring Systems and Growing Diabetic Population are Driving Market Growth
Figure 19 Self-Monitoring Blood Glucose Systems to Dominate the Blood Glucose Monitoring Systems Market, By Product in 2017
Figure 20 Testing Strips to Dominate the Global Self-Monitoring/Traditional Blood Glucose Systems Market in 2017
Figure 21 Sensors to Dominate the Global Continuous Glucose Monitoring Systems Market in 2017
Figure 22 Self/Home Care to Command the Largest Market Share in 2017
Figure 23 Type 2 Diabetes to Command the Largest Market Share in 2017
Figure 24 Fingertip Testing to Command the Largest Market Share in 2017
Figure 25 North America to Witness the Highest Growth Rate During the Forecast Period
Figure 26 Continuous Glucose Monitoring Systems to Register the Highest Growth During the Forecast Period
Figure 27 Blood Glucose Monitoring Systems Market, By Testing Site, 2017 vs 2022 (USD Million)
Figure 28 Blood Glucose Monitoring Systems Market, By Patient Care Setting
Figure 29 Blood Glucose Monitoring Systems Market, By Application, 2017 vs 2022 (USD Million)
Figure 30 North America to Command the Largest Market Share in 2017
Figure 31 North America: Blood Glucose Monitoring Systems Market Snapshot
Figure 32 Europe: Blood Glucose Monitoring Systems Market Snapshot
Figure 33 Diabetes UK: Funds Raised vs Funds Invested
Figure 34 Asia-Pacific: Blood Glucose Monitoring Systems Market Snapshot
Figure 35 RoW: Blood Glucose Monitoring Systems Market Snapshot
Figure 36 Self-Monitoring/Traditional Blood Glucose Systems Market Share, By Key Player, 2016
Figure 37 Continuous Glucose Monitoring Systems Market Share, By Key Player, 2016
Figure 38 Strategies Adopted By Market Players (2014–2017)
Figure 39 Abbott Laboratories: Company Snapshot (2016)
Figure 40 F. Hoffmann-La Roche: Company Snapshot (2016)
Figure 41 Dexcom: Company Snapshot (2016)
Figure 42 Medtronic: Company Snapshot (2016)
Figure 43 Ypsomed: Company Snapshot (2016)
Figure 44 B. Braun Melsungen: Company Snapshot (2016)
Figure 45 Nipro: Company Snapshot (2016)
Figure 46 Sanofi: Company Snapshot (2016)
Generating Response ...
Growth opportunities and latent adjacency in Blood Glucose Monitoring System Market